RN Mobile Menu

Search form


Rheumatoid Arthritis

Malignancies 32% More Likely in RA

Rheumatoid arthritis patients run an increased risk of malignant cancers, independent of biologic and DMARD treatment, researchers report.  (©PhuShutter/Shutterstock.com)

Rheumatoid Arthritis

In this slideshow, we feature a review by Italian rheumatologists who compare subcutaneous and oral methotrexate outcomes in rheumatoid arthritis patients.

Photo courtesy of Hitomi Kobayshi, M.D., Ph.D.

Heart disease in rheumatoid arthritis is well known, but whether it's present in RA patients with no known heart disease or risk factors is not as well known.

(Anatomy of Human Heart ©LiyaGraphics/Shutterstock.com)

Myocardial inflammation/fibrosis has been identified in a study of rheumatoid arthritis patients with no known history of heart disease.

(Side effects ©CatherineLall/Shutterstock.com)

Some biologics produce hypersensitivity reactions more than others, but for most, the events are low, researchers report.

Subcutaneous fluid (©AnnaJurkovska/Shutterstock.com)

Methotrexate is "dramatically" underutilized, prescribed at suboptimal levels, prescribed for too short of periods and is not administered correctly, researchers report.

(Child and adult hands ©PuwadolJaturawutthichai/ShutterStock.com)

Researchers writing in Annals of the Rheumatic Diseases say they have identified a link between juvenile idiopathic arthritis and adult rheumatoid arthritis.


Study supports associations between crystal deposition disease, rheumatoid arthritis and osteoporosis.


Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.